organization · Reporting owner
Acuta Capital Fund, LP
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAS MEDICAL SYSTEMS INCCASM · Entity 158232 | 10% owner | January 04, 2018 | May 01, 2018 |
| IRIDEX CORPIRIX · Entity 7882 | 10% owner | July 03, 2017 | May 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAS MEDICAL SYSTEMS INC
Report date January 04, 2018 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,483,146 |
Ending reported balance
After 2018-03-19 transaction · row 22
22 source rows · reconciled sequenceRow 1 · 2017-12-27 · Purchase · Acquired 4,830 · Balance 3,433,513 F1: The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.7298 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2017-12-28 · Purchase · Acquired 1,380 · Balance 3,434,893 F2: The shares were purchased in multiple transactions at prices ranging from $0.6899 to $0.7049 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2017-12-29 · Purchase · Acquired 8,896 · Balance 3,443,789 F3: The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.77 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 4 · 2018-01-04 · Purchase · Acquired 5,440 · Balance 3,449,229 F4: The shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 5 · 2018-01-17 · Purchase · Acquired 100 · Balance 3,449,329 Row 6 · 2018-02-02 · Purchase · Acquired 1,000 · Balance 3,450,329 Row 7 · 2018-02-06 · Purchase · Acquired 2,811 · Balance 3,453,140 F5: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 8 · 2018-02-09 · Purchase · Acquired 4,964 · Balance 3,458,104 F6: The shares were purchased in multiple transactions at prices ranging from $1.13 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 9 · 2018-02-12 · Purchase · Acquired 884 · Balance 3,458,988 F7: The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 10 · 2018-02-13 · Purchase · Acquired 975 · Balance 3,459,963 F8: The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.20 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 11 · 2018-02-16 · Purchase · Acquired 832 · Balance 3,460,795 F9: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 12 · 2018-02-20 · Purchase · Acquired 2,290 · Balance 3,463,085 F10: The shares were purchased in multiple transactions at prices ranging from $1.10 to $1.16 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 13 · 2018-02-21 · Purchase · Acquired 300 · Balance 3,463,385 Row 14 · 2018-02-23 · Purchase · Acquired 333 · Balance 3,463,718 Row 15 · 2018-02-28 · Purchase · Acquired 2,720 · Balance 3,466,438 F11: The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 16 · 2018-03-01 · Purchase · Acquired 1,814 · Balance 3,468,252 F12: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.08 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 17 · 2018-03-02 · Purchase · Acquired 680 · Balance 3,468,932 Row 18 · 2018-03-08 · Purchase · Acquired 400 · Balance 3,469,332 F13: The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.12 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 19 · 2018-03-09 · Purchase · Acquired 1,180 · Balance 3,470,512 F14: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.10 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 20 · 2018-03-15 · Purchase · Acquired 9,370 · Balance 3,479,882 F15: The shares were purchased in multiple transactions at prices ranging from $1.05 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 21 · 2018-03-16 · Purchase · Acquired 2,176 · Balance 3,482,058 F16: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.26 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 22 · 2018-03-19 · Purchase · Acquired 1,088 · Balance 3,483,146 F17: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.28 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.7298 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: The shares were purchased in multiple transactions at prices ranging from $0.6899 to $0.7049 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.77 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: The shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: The shares were purchased in multiple transactions at prices ranging from $1.13 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7: The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F8: The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.20 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F9: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F10: The shares were purchased in multiple transactions at prices ranging from $1.10 to $1.16 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F11: The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F12: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.08 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F13: The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.12 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F14: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.10 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F15: The shares were purchased in multiple transactions at prices ranging from $1.05 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F16: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.26 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F17: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.28 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
IRIDEX CORP
Report date July 03, 2017 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,344,720 |
Ending reported balance
After 2017-08-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-08-16 · Purchase · Acquired 2,260 · Balance 1,343,984 F1: The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.47 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2017-08-22 · Purchase · Acquired 500 · Balance 1,344,484 F2: The shares were purchased in multiple transactions at prices ranging from $8.41 to $8.44 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2017-08-25 · Purchase · Acquired 236 · Balance 1,344,720 F3: The shares were purchased in multiple transactions at prices ranging from $8.66 to $8.67 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.47 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: The shares were purchased in multiple transactions at prices ranging from $8.41 to $8.44 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: The shares were purchased in multiple transactions at prices ranging from $8.66 to $8.67 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,088 | $1.25 | $1,361.41 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 22 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,483,146 F17 · price: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.28 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 16, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,176 | $1.25 | $2,720.00 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 21 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,482,058 F16 · price: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.26 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 9,370 | $1.16 | $10,853.27 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 20 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,479,882 F15 · price: The shares were purchased in multiple transactions at prices ranging from $1.05 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,180 | $1.07 | $1,265.31 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 19 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,470,512 F14 · price: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.10 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 08, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 400 | $1.10 | $439.00 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 18 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,469,332 F13 · price: The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.12 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 680 | $1.08 | $734.40 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 17 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,932 Read SEC document |
| March 01, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,814 | $1.07 | $1,949.32 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 16 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,252 F12 · price: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.08 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,720 | $1.15 | $3,127.46 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 15 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,466,438 F11 · price: The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 333 | $1.13 | $376.29 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 14 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,463,718 Read SEC document |
| February 21, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 300 | $1.10 | $330.00 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 13 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,463,385 Read SEC document |
| February 20, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,290 | $1.11 | $2,548.31 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 12 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,463,085 F10 · price: The shares were purchased in multiple transactions at prices ranging from $1.10 to $1.16 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 832 | $1.17 | $972.77 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 11 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,460,795 F9 · price: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 975 | $1.18 | $1,153.43 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 10 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,459,963 F8 · price: The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.20 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 884 | $1.15 | $1,013.24 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 9 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458,988 F7 · price: The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 09, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,964 | $1.15 | $5,728.46 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 8 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458,104 F6 · price: The shares were purchased in multiple transactions at prices ranging from $1.13 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,811 | $1.17 | $3,293.93 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 7 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453,140 F5 · price: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,000 | $1.19 | $1,190.00 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 6 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,450,329 Read SEC document |
| January 17, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 100 | $1.05 | $105.00 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 5 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,449,329 Read SEC document |
| January 04, 2018 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 5,440 | $0.86 | $4,662.08 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 4 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,449,229 F4 · price: The shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 29, 2017 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 8,896 | $0.74 | $6,574.14 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 3 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,443,789 F3 · price: The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.77 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 28, 2017 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,380 | $0.70 | $965.45 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 2 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,434,893 F2 · price: The shares were purchased in multiple transactions at prices ranging from $0.6899 to $0.7049 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 27, 2017 Filed May 1, 2018 17:14 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,830 | $0.72 | $3,475.67 |
DisclosureSEC source: 0001209191-18-027154 · doc4.xml · nonDerivative · entry 1 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,433,513 F1 · price: The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.7298 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 26, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 9,660 | $0.72 | $6,917.53 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 30 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,428,683 F27 · price: The shares were purchased in multiple transactions at prices ranging from $0.6796 to $0.72 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 19, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 7,476 | $0.65 | $4,845.20 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 29 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,419,023 F26 · price: The shares were purchased in multiple transactions at prices ranging from $0.6396 to $0.669 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 18, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,760 | $0.66 | $1,810.28 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 28 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411,547 F25 · price: The shares were purchased in multiple transactions at prices ranging from $0.648 to $0.6787 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 3,450 | $0.64 | $2,201.10 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 27 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,408,787 F24 · price: The shares were purchased in multiple transactions at prices ranging from $0.6299 to $0.65 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 5,520 | $0.63 | $3,457.18 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 26 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,405,337 F23 · price: The shares were purchased in multiple transactions at prices ranging from $0.6199 to $0.6388 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 13, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,070 | $0.62 | $1,284.85 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 25 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,399,817 F22 · price: The shares were purchased in multiple transactions at prices ranging from $0.6189 to $0.6299 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 08, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 222 | $0.90 | $199.80 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 24 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,397,747 Read SEC document |
| September 07, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,464 | $0.89 | $2,182.36 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 23 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,397,525 F21 · price: The shares were purchased in multiple transactions at prices ranging from $0.87 to $0.89 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 29, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,088 | $0.93 | $1,009.56 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 22 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,395,061 F20 · price: The shares were purchased in multiple transactions at prices ranging from $0.91 to $0.96 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 25, 2017 Filed May 1, 2018 21:01 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 236 | $8.67 | $2,045.13 |
DisclosureSEC source: 0001209191-18-027146 · doc4.xml · nonDerivative · entry 3 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344,720 F3 · price: The shares were purchased in multiple transactions at prices ranging from $8.66 to $8.67 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 24, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,720 | $0.95 | $2,590.80 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 21 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,393,973 F19 · price: The shares were purchased in multiple transactions at prices ranging from $0.95 to $0.96 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 5,576 | $0.96 | $5,350.17 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 20 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,391,253 F18 · price: The shares were purchased in multiple transactions at prices ranging from $0.95 to $0.99 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 22, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 816 | $0.99 | $803.76 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 19 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,385,677 F17 · price: The shares were purchased in multiple transactions at prices ranging from $0.98 to $0.99 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 22, 2017 Filed May 1, 2018 21:01 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 500 | $8.42 | $4,212.25 |
DisclosureSEC source: 0001209191-18-027146 · doc4.xml · nonDerivative · entry 2 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344,484 F2 · price: The shares were purchased in multiple transactions at prices ranging from $8.41 to $8.44 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 18, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,565 | $0.99 | $1,550.76 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 18 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,384,861 F16 · price: The shares were purchased in multiple transactions at prices ranging from $0.99 to $1.00 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,284 | $0.96 | $4,133.20 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 17 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,383,296 F15 · price: The shares were purchased in multiple transactions at prices ranging from $0.9499 to $1.00 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 333 | $0.99 | $329.67 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 16 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,379,012 Read SEC document |
| August 16, 2017 Filed May 1, 2018 21:01 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 2,260 | $8.40 | $18,991.68 |
DisclosureSEC source: 0001209191-18-027146 · doc4.xml · nonDerivative · entry 1 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,343,984 F1 · price: The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.47 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,720 | $0.96 | $2,624.53 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 15 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,378,679 F14 · price: The shares were purchased in multiple transactions at prices ranging from $0.9598 to $0.97 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2017 Filed May 1, 2018 20:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 555 | $8.55 | $4,742.97 |
DisclosureSEC source: 0001209191-18-027145 · doc4.xml · nonDerivative · entry 30 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341,724 F30 · price: The shares were purchased in multiple transactions at prices ranging from $8.52 to $8.56 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 11, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 5,440 | $1.00 | $5,449.79 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 14 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375,959 F13 · price: The shares were purchased in multiple transactions at prices ranging from $0.98 to $1.01 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 11, 2017 Filed May 1, 2018 20:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 5,365 | $8.48 | $45,474.81 |
DisclosureSEC source: 0001209191-18-027145 · doc4.xml · nonDerivative · entry 29 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341,169 F29 · price: The shares were purchased in multiple transactions at prices ranging from $8.44 to $8.50 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 8,656 | $0.98 | $8,502.79 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 13 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,370,519 F12 · price: The shares were purchased in multiple transactions at prices ranging from $0.958 to $0.998 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2017 Filed May 1, 2018 20:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 2,852 | $8.46 | $24,129.92 |
DisclosureSEC source: 0001209191-18-027145 · doc4.xml · nonDerivative · entry 28 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335,804 F28 · price: The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.61 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,080 | $0.99 | $4,046.14 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 12 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,361,863 F11 · price: The shares were purchased in multiple transactions at prices ranging from $0.99 to $1.00 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2017 Filed May 1, 2018 20:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 9,730 | $8.60 | $83,632.27 |
DisclosureSEC source: 0001209191-18-027145 · doc4.xml · nonDerivative · entry 27 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,332,952 F27 · price: The shares were purchased in multiple transactions at prices ranging from $8.50 to $8.66 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed May 1, 2018 17:13 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 26,384 | $0.99 | $26,004.07 |
DisclosureSEC source: 0001209191-18-027153 · doc4.xml · nonDerivative · entry 11 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,357,783 F10 · price: The shares were purchased in multiple transactions at prices ranging from $0.955 to $1.02 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed May 1, 2018 20:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 13,185 | $8.18 | $107,871.76 |
DisclosureSEC source: 0001209191-18-027145 · doc4.xml · nonDerivative · entry 26 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323,222 F26 · price: The shares were purchased in multiple transactions at prices ranging from $8.10 to $8.37 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.